Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BONE THERAPEUTICSCS S.A.
No Price
Closing Price XBRU 29.04.2026:
0,002 EUR
29.04.2026 10:52
Current Prices from BONE THERAPEUTICSCS S.A.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
EURONEXT - EURONEXT BRUSSELS
BIOS.BR
EUR
29.04.2026 10:52
0,002 EUR
0,00 EUR
London
0R55.L
EUR
29.04.2026 07:31
0,002 EUR
-0,0002 EUR
-8,33 %
Share Float & Liquidity
Free Float92,39 %
Shares Float603,17 M
Shares Outstanding652,86 M
Company Profile for BONE THERAPEUTICSCS S.A. Share
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
